Sooma tDCS Device

In the USA, Sooma tDCS is labeled as an investigational device. Its use is limited to researchers or medical doctors. In the EU, Sooma tDCS adds a new dimension to the clinical routine for treating patients with major depression or chronic pain. Sooma tDCS delivery kit includes all you need to get started with your tDCS trials.

• Safe and well tolerated
• Effective
• Easy to use, designed for clinical routine or research studies
• Affordable and cost-effective
• Can be used as monotherapy or as adjunct to other treatments

• Intuitive workflow-based operation
• Single button, no possibility for accidental modification of treatment protocol
• Continuous contact monitoring for dose control
• Current ramp-up and ramp-down for patient comfort
• Treatment counter for use supervision
• Sham-mode for double-blind operation

In the USA, this device is available for investigational use. Sooma tDCS is a class IIa medical device CE approved in the EU for treatment of Major Depressive Disorder, Fibromyalgia, and Neuropathic pain. It is an effective and easy-to-use solution for professionals, designed for routine clinical use in co-operation with leading psychiatrists and neurophysiologists.

The stimulation is gentle and very well tolerated. It can be used as an alternative to or in combination with psychotherapy, pharmaceuticals, and other neuromodulation treatments.

Sooma tDCS is an optimal tool for outcome studies. It supports double-blind condition and can be configured for multiple study protocols. Further, it ensures that every member of the study team perform stimulation in the same way.

• Adjustable current up to 3 mA in increments of 0.1 mA
• Adjustable application time up to 30 min in increments of 30 sec
• Current ramp up / ramp down: 0.1 mA/s
• Maximum output voltage: 18 V
• Battery life: 100 hours. User replaceable.

• Single-button session control
• Compact size: 12 cm x 7.3 cm x 2.2 cm
• Weight (incl. batteries): 0.2 kg
• Touch-proof electrode connection in accordance with DIN 42802
• Ingress protection: IP21

When starting a session, two electrodes are positioned over the stimulation area using a head cap that offers the intuitive usability required in clinical routine. The device ensures that the contact between scalp and electrodes is acceptable. When acceptable contact is achieved, the device allows the user to start the stimulation. Sooma offers several sizes of head caps to accommodate to different head sizes. The whole treatment preparation usually takes less than 5 minutes.

During a stimulation session, direct current is applied directly to the scalp at the stimulation area. The current intensity is 2 mA, which is 400 to 500 times less than in traditional electroconvulsive therapy (ECT).